Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

A seminar on preclinical R&D strategic cooperation was held between Medicilon and Yichang Humanwell

2020-08-20
|
Page View:

Yichang, Hubei, Aug 13, 2020 – A seminar on preclinical R&D strategic cooperation was held between Medicilon. INC (Stock Code: 688202. SH) and Yichang Humanwell Pharmaceutical CO.LTD (Stock Code: 600079. SH). During the meeting, the two companies discussed the vision of cooperation in the future, hoping to strengthen the relationship, jointly promote the research and development process, and provide better choices for doctors and patients to cure diseases.

 A seminar on preclinical R&D strategic cooperation was held between Medicilon and Yichang Humanwell
Return
Relevant newsRelevant news